NL134264C - - Google Patents

Info

Publication number
NL134264C
NL134264C NL134264DA NL134264C NL 134264 C NL134264 C NL 134264C NL 134264D A NL134264D A NL 134264DA NL 134264 C NL134264 C NL 134264C
Authority
NL
Netherlands
Application number
Publication of NL134264C publication Critical patent/NL134264C/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
NL134264D NL134264C (en)

Publications (1)

Publication Number Publication Date
NL134264C true NL134264C (en)

Family

ID=1854731

Family Applications (1)

Application Number Title Priority Date Filing Date
NL134264D NL134264C (en)

Country Status (1)

Country Link
NL (1) NL134264C (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7034078B2 (en) 1997-08-12 2006-04-25 Exxonmobil Chemical Patents Inc. Blends made from propylene ethylene polymers

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7034078B2 (en) 1997-08-12 2006-04-25 Exxonmobil Chemical Patents Inc. Blends made from propylene ethylene polymers

Similar Documents

Publication Publication Date Title
AU2003210755A1 (en) Targeted drug delivery methods
AU3064992A (en) Compositions containing k-252 compounds for potentiation of neurotrophin activity
AU2160492A (en) Treatment of human diseases involving dysregulation or dysfunction of the nervous system
AU2006343317A1 (en) Treating cancer with cardiac glycosides
AU3183293A (en) Method for administration of azauridine for the treatment of rheumatoid arthritis
AU2323492A (en) Method for inhibiting allograft rejection
AU2620600A (en) Composition of anti-hiv drugs and anti-cortisol compounds and method for decreasing the side effects of anti-hiv drugs in a human
AU1655388A (en) Pharmaceutical composition comprising a compound containing sulfhydryl group(s) for the treatment of otitis
ATE83379T1 (en) COCCIDIOCIDE AGENT.
AU2003287635A1 (en) Imaging protein-protein interactions in living subjects
AU3203871A (en) Process for the production of a sugar supplement injection solution
ATE212228T1 (en) A HOMEOPATICAL SOLUTION CONTAINING NUCLEIC ACID
AU2003303524A1 (en) Methods of improving health-related quality of life in individuals with systemic lupus erythematosus
AU1501370A (en) Improvements in or relating to organic compounds
AU2003225813A1 (en) Preemptive prophylaxis of migraine
AU1150888A (en) Medicament containing local anesthetics and nucleosides and its use for treating muscular injuries
AU2001268474A1 (en) Use of amp kinase activators for treatment of type 2 diabetes and insulin resistance
AU2002257333A1 (en) Novel treatment of neurodegenerative diseases by altering levels of trkb isoforms and/or trkc isoforms
AU2554792A (en) Method of neutralizing il-1 using dsrnas
ATE69551T1 (en) COMPOSITION FOR TREATMENT OF MALIGNANT TUMORS, ESPECIALLY IN ANIMALS.
ATE77749T1 (en) COCCIDIOCIDE AGENT.
ATE82128T1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CANCER.
AT268519B (en) Process for the preparation of hydrogenated moenomycin
AU2003205100A1 (en) Novel cholesterol absorption lowering agents
AU1312800A (en) Method and composition for treating ischemia and sickle cell anemia